We are live on ! Find out more
KYTH

KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH

Delisted

KYTH was delisted on the 30th of September, 2015.

Back to rankings

83 hedge funds and large institutions have $453M invested in KYTHERA BIOPHARMACEUTICALS, INC COM in 2013 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 34 increasing their positions, 14 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 4

143% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 14

96% more capital invested

Capital invested by funds: $231M → $453M (+$222M)

28% more funds holding

Funds holding: 65 → 83 (+18)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
83
Holders Change
+18
Holders Change %
+27.69%
% of All Funds
2.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
22
Increased
34
Reduced
14
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WRF
Waddell & Reed Financial
Kansas
+$12.7M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$7.66M
3
CCI
Columbus Circle Investors
+$7.01M
4
PAI
Palo Alto Investors
California
+$6.97M
5
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$6.11M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$10.4M
2
BCM
BBT Capital Management
Texas
-$4.82M
3
IA
Investor AB
Sweden
-$2.84M
4
SCA
SAC Capital Advisors
Connecticut
-$2.71M
5
SGAM
Smith Group Asset Management
Texas
-$899K
Name Holding Trade Value Shares
Change 		Change in
Stake
EI
26
EAM Investors
California
$2.75M +$1.8M +60,219 New
DCM
27
Driehaus Capital Management
Illinois
$2.23M +$524K +17,516 +56%
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$2.2M -$797K -26,639 -36%
RFC
29
Russell Frank Company
Washington
$2.01M +$1.32M +44,076 New
TCIM
30
TIAA CREF Investment Management
New York
$1.9M +$10.9K +365 +0.9%
Geode Capital Management
31
Geode Capital Management
Massachusetts
$1.85M +$475K +15,890 +65%
FM
32
Forward Management
California
$1.7M +$592K +19,797 +60%
AllianceBernstein
33
AllianceBernstein
Tennessee
$1.69M +$937K +31,326 +562%
GGHC
34
Gilder Gagnon Howe & Co
New York
$1.66M +$1.09M +36,321 New
ROTUOC
35
Regents of the University of California
California
$1.6M +$519K +17,356 +99%
BIM
36
BlackRock Investment Management
Delaware
$1.31M +$65.3K +2,182 +8%
Ameriprise
37
Ameriprise
Minnesota
$1.18M +$751K +25,102 +3,947%
DMK
38
David M. Knott
$1.14M – – –
PIM
39
Partner Investment Management
California
$1.08M -$424K -14,165 -38%
Charles Schwab
40
Charles Schwab
California
$976K +$112K +3,735 +22%
WC
41
Wexford Capital
Florida
$912K +$598K +20,000 New
JAFL
42
Jay A. Fishman Ltd
Michigan
$889K – – –
Deutsche Bank
43
Deutsche Bank
Germany
$849K +$272K +9,088 +95%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$835K +$15K +500 +3%
TA
45
Teachers Advisors
New York
$656K +$27.2K +911 +7%
PAM
46
Paradigm Asset Management
New York
$567K +$371K +12,400 New
NFA
47
Nationwide Fund Advisors
Ohio
$508K +$170K +5,682 +104%
OWIM
48
Old West Investment Management
California
$507K +$3.77K +126 +1%
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$506K +$331K +11,083 New
BF
50
BOK Financial
Oklahoma
$495K +$325K +10,860 New
1
2
3 4

KYTH Hedge Fund Activity: Q3 2013 in Review

83 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) for Q3 2013, worth a combined $453M — up 96% from $231M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new KYTH positions and 4 closed out — a net gain of 18 holders — while 34 added to existing stakes and 14 trimmed.

The largest buyer was Waddell & Reed Financial, opening a new position worth an estimated $12.7M. The largest seller was PFM Health Sciences, cutting an estimated $10.4M.

  • 83 institutional investors held KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) as of Q3 2013, up from 65 in Q2 2013.
  • Funds reported $453M of KYTHERA BIOPHARMACEUTICALS, INC COM stock for Q3 2013, up 96% quarter-over-quarter.
  • 22 funds opened new KYTHERA BIOPHARMACEUTICALS, INC COM positions in Q3 2013 and 4 closed out, a net change of +18 holders.
  • The largest KYTHERA BIOPHARMACEUTICALS, INC COM buyer in Q3 2013 was Waddell & Reed Financial, an estimated $12.7M added.
  • The largest KYTHERA BIOPHARMACEUTICALS, INC COM seller in Q3 2013 was PFM Health Sciences, an estimated $10.4M sold.

Based on aggregated 13F filings for Q3 2013.